Geoffrey Lippa

Dr. Geoffrey Lippa

Alfred University
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2012 in Organometallics
Verified
Journal Article
Closed access
JRJennifer L. Rhinehart
Jennifer L. Rhinehart
KMKimberly A. Manbeck
Kimberly A. Manbeck
SBSara K. Buzak
Sara K. Buzak
GLGeoffrey Lippa
Geoffrey Lippa
WBWilliam Brennessel
William Brennessel
WJWilliam D. Jones
William D. Jones

25 October 2012 in Biochemistry
Verified
Journal Article
Closed access
JSJason D. Salter
Jason D. Salter
GLGeoffrey Lippa
Geoffrey Lippa
IBIvan A. Belashov
Ivan A. Belashov
JWJoseph Wedekind
Joseph Wedekind

10 March 2021 in Crystals
Verified
Journal Article
Open access
PDF file
YSYoshita Srivastava
Yoshita Srivastava
RBRachel Bonn-Breach
Rachel Bonn-Breach
SCSai Shashank Chavali
Sai Shashank Chavali
GLGeoffrey Lippa
Geoffrey Lippa
JJJermaine L. Jenkins
Jermaine L. Jenkins
JWJoseph Wedekind
Joseph Wedekind
RNA plays a central role in all organisms and can fold into complex structures to orchestrate function. Visualization of such structures often requires crystallization, which can be a bottleneck in the structure-determination process. To promote crystallization, an RNA-recognition motif (RRM) of the U1A spliceosomal protein has been co-opted as a crystallization module. Specifically, the U1-snRNA hairpin II (hpII) single-stranded loop recognized by U1A can be transplanted into an RNA target to promote crystal contacts and to attain phase information via molecular replacement or anomalous diffraction methods using selenomethionine. Herein, we produced the F37M/F77M mutant of U1A to augment the phasing capability of this powerful crystallization module. Selenomethionine-substituted U1A(F37M/F77M) retains high affinity for hpII (KD of 59.7 ± 11.4 nM). The 2.20 Å resolution crystal structure reveals that the mutated sidechains make new S-π interactions in the hydrophobic core and are useful for single-wavelength anomalous diffraction. Crystals were also attained of U1A(F37M/F77M) in complex with a bacterial preQ1-II riboswitch. The F34M/F37M/F77M mutant was introduced similarly into a lab-evolved U1A variant (TBP6.9) that recognizes the internal bulged loop of HIV-1 TAR RNA. We envision that this short RNA sequence can be placed into non-essential duplex regions to promote crystallization and phasing of target RNAs. We show that selenomethionine-substituted TBP6.9(F34M/F37M/F77M) binds a TAR variant wherein the apical loop was replaced with a GNRA tetraloop (KD of 69.8 ± 2.9 nM), laying the groundwork for use of TBP6.9(F34M/F37M/F77M) as a crystallization module. These new tools are available to the research community.

1 April 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
GLGeoffrey Lippa
Geoffrey Lippa
MMMadison Muehl
Madison Muehl
JLJoshua Lapham
Joshua Lapham
Viruses, like human immunodeficiency virus (HIV), have the ability to hijack host pathways to promote disease pathogenesis. The process of ubiquitination is used by the cell for regulating signal transduction, DNA replication, cellular development, transcription, and the cell cycle. Ubiquitination and the proteasome work together to degrade a variety of cellular target proteins involved in the processes described. The covalent attachment of a ubiquitin protein to a cellular substrate requires a multi‐protein complex consisting of a scaffold protein, adaptor module, substrate receptor, RING protein, and E2 protein. In HIV, the Cullin‐RING E3 ligase complex utilizing Cullin5, Rbx2, E2, Elongin B, Elongin C, and Vif (viral infectivity factor), amongst other accessory proteins results in the targeted degradation of antiretroviral factor APOBEC3G. Other viruses have followed suit countering these natural processes by expressing viral proteins capable of sequestering or enhancing host ubiquitination conducted by CRL complexes. Research efforts have been made in discovering both host proteins targeted in this fashion and those viral proteins responsible for this aberrant activity. Through bioinformatics and structural analysis new potential viral proteins involved in the above CRL complex have been discovered. These targets are predicted to play a role in viral fitness for Hepatitis C virus (NS5A), West Nile Virus (NS1), and Lassa virus (Z‐protein) due to their similarities with the host substrate receptor SOCS2. We are currently in the process of co‐expressing parts of the CRL complex with these viral targets in E. coli with the goal of evaluating their interactions. Utilizing in vitro pull‐down assays and thermodynamic techniques we hope to verify the viral proteins involved in the CRL complex and their mechanisms of interaction laying the groundwork for new avenues of anti‐viral therapeutics. Support or Funding Information Funding was achieved through Alfred Research Grants for Undergraduate Research. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .